The combination is generally well-tolerated, but potential side effects include fatigue, headache, or dizziness from Zofran, alongside semaglutide-related effects like nausea, diarrhea, or reduced appetite
The clinical research base is among the deepest of any GLP-1 agonist
This triple targeting is a promising development but note Retatrutide is not FDA approved yet
This was supported by higher extracellular concentrations and faster secretion rates of HB and AcAc in cells metabolizing C8:0 compared to C10:0
These medications are serious treatments that licensed doctors must approve, sticking to proven medical standards
Ultimately, your weight loss journey is a personal one, and your Shapely team will be by your side to help you achieve your best results Typically, we find that patients of our weight loss program in Los Gatos, California who are taking GLP-1 agonists such as Ozempic and Wegovy will lose 10% of weight by 6 months and 15% within 1 year